For investigative sites, selecting studies for increased patient centricity, whether through decentralized trials, patient input in study design, or remote monitoring initiatives, can improve enrollment.
About the Author:
Kurt Mussina, President, Frenova Renal Research and SVP, Global Medical Office, Fresenius Medical Care
Kurt Mussina brings more than 30 years of international business success to his role at Frenova, including a record of leadership and achievement structuring and orchestrating global business development teams in the contract research services industry. As president, he is responsible for driving Frenova’s global growth and success.